Latest Capital Expenditure News

Toubani Resources has appointed Ausenco as the EPCM contractor for its Kobada Gold Project in Mali, marking a pivotal step toward project execution and a Final Investment Decision.

Global Lithium Resources Limited has achieved major milestones this quarter with a Native Title Mining Agreement and Mining Lease granted for its Manna Lithium Project, while exploration at Marble Bar reveals encouraging signs of a large gold system.

Alliance Nickel’s September 2025 quarterly report highlights a robust Definitive Feasibility Study for its NiWest Nickel-Cobalt Project, alongside ongoing strategic partnership talks and solid financial footing.

Kelsian Group reported steady FY25 financial results with a 9.5% revenue increase and reaffirmed FY26 EBITDA guidance, while progressing the strategic divestment of its tourism assets to sharpen focus on core transport services.

IperionX has boosted titanium powder production capacity by 60% and secured US$75 million in Department of War funding to scale up to 1,400 tonnes per annum by 2027, aiming to become the largest and lowest-cost US titanium producer.

Lynas Rare Earths delivered record quarterly sales revenue of A$200.2 million in Q1 FY26, bolstered by a successful $932 million equity raise and strategic partnerships aimed at securing critical rare earth supply chains outside China.

Champion Iron Limited reported a robust FY2026 second quarter with record sales, improved earnings, and steady progress on its DRPF project, while declaring its ninth consecutive dividend.

Pacgold has secured the White Dam Gold Operation, unlocking a pathway to near-term production and cash flow, while advancing exploration at Alice River and St George projects backed by a $13 million capital raise.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Bioxyne Limited has reported a record quarterly revenue of A$14.1 million for Q1 FY26, driven by strong demand in Europe and Australia, alongside a strategic dual listing on the Frankfurt Stock Exchange.

SomnoMed reports a strong start to FY26 with 13.5% revenue growth and confirms the Clayton Sleep Institute as the first US site for its pivotal Rest Assure clinical study, backed by FDA protocol agreement.

Mineral Resources Limited reported a record quarter with Onslow Iron reaching full capacity and lithium prices surging 31%, while maintaining FY26 guidance and strengthening its Board.